Voya Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,569
| Closed | -$215K | – | 221 |
|
|
2024
Q3 | $215K | Buy |
+2,569
| New | +$196K | 0.02% | 215 |
|
|
2023
Q1 | – | Sell |
-3,681
| Closed | -$314K | – | 241 |
|
|
2022
Q4 | $314K | Sell |
3,681
-399
| -10% | -$31.6K | 0.04% | 182 |
|
|
2022
Q3 | $257K | Buy |
4,080
+567
| +16% | +$35.8K | 0.03% | 201 |
|
|
2022
Q2 | $219K | Buy |
+3,513
| New | +$218K | 0.03% | 228 |
|
|
2021
Q2 | – | Sell |
-21,158
| Closed | -$1.39M | – | 384 |
|
|
2021
Q1 | $1.39M | Sell |
21,158
-810
| -4% | -$52.2K | 0.05% | 241 |
|
|
2020
Q4 | $1.25M | Buy |
21,968
+4,389
| +25% | +$265K | 0.05% | 237 |
|
|
2020
Q3 | $1.09M | Buy |
17,579
+6,944
| +65% | +$482K | 0.05% | 241 |
|
|
2020
Q2 | $793K | Sell |
10,635
-10,270
| -49% | -$787K | 0.04% | 285 |
|
|
2020
Q1 | $1.59M | Buy |
20,905
+537
| +3% | +$37.1K | 0.09% | 161 |
|
|
2019
Q4 | $1.32M | Buy |
20,368
+2,144
| +12% | +$140K | 0.07% | 215 |
|
|
2019
Q3 | $1.15M | Buy |
18,224
+12,747
| +233% | +$833K | 0.06% | 223 |
|
|
2019
Q2 | $367K | Buy |
5,477
+902
| +20% | +$59.3K | 0.02% | 445 |
|
|
2019
Q1 | $291K | Sell |
4,575
-1,042
| -19% | -$69.3K | 0.02% | 487 |
|
|
2018
Q4 | $348K | Sell |
5,617
-1,775
| -24% | -$124K | 0.02% | 401 |
|
|
2018
Q3 | $566K | Sell |
7,392
-2,264
| -23% | -$171K | 0.03% | 330 |
|
|
2018
Q2 | $679K | Sell |
9,656
-723
| -7% | -$51.1K | 0.04% | 266 |
|
|
2018
Q1 | $776K | Sell |
10,379
-3,638
| -26% | -$289K | 0.05% | 253 |
|
|
2017
Q4 | $1.02M | Sell |
14,017
-11,785
| -46% | -$895K | 0.07% | 230 |
|
|
2017
Q3 | $2.09M | Sell |
25,802
-4,491
| -15% | -$343K | 0.14% | 138 |
|
|
2017
Q2 | $2.15M | Sell |
30,293
-2,280
| -7% | -$152K | 0.15% | 125 |
|
|
2017
Q1 | $2.19M | Sell |
32,573
-2,269
| -7% | -$160K | 0.17% | 124 |
|
|
2016
Q4 | $2.51M | Buy |
34,842
+2,845
| +9% | +$211K | 0.22% | 95 |
|
|
2016
Q3 | $2.49M | Buy |
31,997
+684
| +2% | +$55.6K | 0.25% | 79 |
|
|
2016
Q2 | $2.58M | Sell |
31,313
-65
| -0.2% | -$5.77K | 0.3% | 67 |
|
|
2016
Q1 | $2.89M | Buy |
31,378
+1,504
| +5% | +$136K | 0.4% | 48 |
|
|
2015
Q4 | $3.05M | Buy |
29,874
+1,436
| +5% | +$149K | 0.45% | 44 |
|
|
2015
Q3 | $2.73M | Buy |
28,438
+22,879
| +412% | +$2.54M | 0.49% | 40 |
|
|
2015
Q2 | $642K | Buy |
5,559
+1,261
| +29% | +$138K | 0.11% | 138 |
|
|
2015
Q1 | $433K | Buy |
+4,298
| New | +$436K | 0.08% | 193 |
|
Other funds holding GILD
Voya Financial Advisors's GILD Position: Q4 2024 in Review
Voya Financial Advisors sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 2,569 shares — an estimated $215K sold.
Voya Financial Advisors first reported a position in GILD in Q1 2015 and held it in 29 quarters. The position peaked at $3.05M in Q4 2015. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Voya Financial Advisors reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
- Voya Financial Advisors sold 2,569 Gilead Sciences shares in Q4 2024, an estimated $215K.
- Voya Financial Advisors first reported a position in Gilead Sciences in Q1 2015 and held it in 29 quarters.
- Voya Financial Advisors's Gilead Sciences position peaked at $3.05M in Q4 2015.
- 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Voya Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.